Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app bring HIV prevention to trans sex workers?

NCT ID NCT07516691

Prevention Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a digital teleconsultation program called E-PrevenT to help transgender sex workers and their clients access HIV and STI prevention services. The program aims to reach people who are often left out of traditional prevention efforts. Researchers will enroll 250 participants and track how many use the service.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital teleconsultation program (E-PrevenT)
What this could lead to
If successful, this could provide a scalable way to bring HIV/STI prevention to hard-to-reach transgender sex workers and their clients.
What could go wrong
This is an early-stage feasibility study, not a treatment trial. It may not show a significant increase in prevention access, and results may not apply to other populations or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Population of the "escort clients" dating strategy: Dating site users (trans sex workers and their clients) Population of the RDS strategy (Respondent Driven Sampling) : Seeds: trans SW on sex work followed-up in health programs of Bichat Acceptess- T. Seeds with regular follow-up and regular clients will be preferred. Fruits: clients invited by trans sex workers to participate to E-PrevenT programs

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 'For population of E-prevent telemedicine service users : * Individuals aged ≥18 years * Registered on a trans escort-client dating website or having sexual relations with trans individuals in exchange for money * Agreeing to complete at least one teleconsultation through the E-PrevenT program * Agreeing to provide a phone number and an email address for the teleconsultation * No verbal objection to participating in the study For population of trans individuals invited to collaborate in the study (seeds of the RDS strategy): * Trans or non-binary individuals aged ≥18 years * Engaged in sexual activity in exchange for money (sex work) * Commitment to complete sexual health training sessions (twice per year) * No verbal objection to participating in the study Exclusion Criteria: * Person under guardianship, curatorship or other French legal protections schemes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Bichat-Claude Bernard

    Paris, Ap-hp DRCI, 75018, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.